Reporting Manager
Monograph Capital Partners I, L.P.
Symbol
URGN
Shares outstanding
46,589,722 shares
Disclosed Ownership
838,615 shares
Ownership
1.8%
Form type
SCHEDULE 13D/A
Filing time
09 Jun 2025, 19:19:46 UTC
Date of event
05 Jun 2025

Quoteable Key Fact

"Monograph Capital Holdings Advisors, LLC disclosed 1.8% ownership in UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN) on 05 Jun 2025."

Quick Takeaways

  • Monograph Capital Holdings Advisors, LLC filed SCHEDULE 13D/A for UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN).
  • Disclosed ownership: 1.8%.
  • Date of event: 05 Jun 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 09 Jun 2025, 19:19.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Monograph Capital Partners I, L.P. 1.8% 838,615 0 838,615 /s/ Michael LaGatta Michael LaGatta / Partner and Authorized Signatory 0001864082
Monograph Capital Partners I GenPar, LP 1.8% 838,615 0 838,615 /s/ Michael LaGatta Michael LaGatta / Partner and Authorized Signatory
Monograph Capital Holdings Advisors, LLC 1.8% 838,615 0 838,615 /s/ Michael LaGatta Michael LaGatta / Partner and Authorized Signatory 0001988760
Fred Cohen 1.9% 838,615 15,000 838,615 /s/ Michael LaGatta Michael LaGatta/ Attorney-in-fact (1) 0001339358
Charles Conn 1.8% 838,615 0 838,615 /s/ Michael LaGatta Michael LaGatta/ Attorney-in-fact (2)